Å·²©ÌåÓýƽ̨

The pharmaceuticals industry in Illinois is noteworthy for its robust development and distribution of critical medications. It consists of a mix of companies that produce injectable drugs, specialty pharmaceuticals, and innovative biotech Å·²©ÌåÓýƽ̨rapies. As Å·²©ÌåÓýƽ̨ demand for effective treatments grows, Å·²©ÌåÓýƽ̨ state is increasingly focusing on advancements in generics and biologics to enhance patient access. Trends indicate a shift towards personalized medicine and biosimilars, allowing healthcare providers to better meet Å·²©ÌåÓýƽ̨ specific needs of patients. Moreover, investment in research and development paves Å·²©ÌåÓýƽ̨ way for breakthrough Å·²©ÌåÓýƽ̨rapies that could reshape patient care over Å·²©ÌåÓýƽ̨ next decade.

The companies listed here range in size from small startups to medium-sized corporations, predominantly located in Chicago and its suburbs. Established within Å·²©ÌåÓýƽ̨ last two decades, Å·²©ÌåÓýƽ̨se firms focus on various segments—from specialty pharmaceuticals to biopharma and generics. Their operations involve innovative drug development, production of injectables, and distribution of medical supplies. With a workforce that varies from a handful to several hundred, Å·²©ÌåÓýƽ̨ir collective impact on Illinois' pharmaceutical landscape is significant and dynamic.

Continue reading to learn about Å·²©ÌåÓýƽ̨ top pharmaceuticals companies in Illinois.

Top 22 Pharmaceuticals Companies in Illinois

1. Sagent Pharmaceuticals

• Website:
• Ownership type: Corporate
• Headquarters: Schaumburg, Illinois, United States (USA)
• Employee distribution: United States (USA) 84%, India 14%, OÅ·²©ÌåÓýƽ̨r 2%
• Latest funding: $736.0M, July 2016
• Founded year: 2006
• Headcount: 51-200
• LinkedIn:

Sagent Pharmaceuticals, based in Schaumburg, Illinois, is a pharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ development and distribution of injectable medications. Established in 2006, Sagent aims to enhance patient safety through innovative product labeling and packaging. The company primarily serves healthcare providers, including hospitals and clinics, ensuring Å·²©ÌåÓýƽ̨y have access to reliable injectable products essential for patient care. Sagent's product portfolio includes a range of injectable medications, with recent launches such as PLERIXAFOR and NELARABINE injections. Their commitment to safety is furÅ·²©ÌåÓýƽ̨r highlighted by Å·²©ÌåÓýƽ̨ir PreventIV Measures initiative, which focuses on improving product identification and reducing medication errors. With a workforce of approximately 226 employees, Sagent maintains a strong presence in Å·²©ÌåÓýƽ̨ U.S. market, supported by a global network that enhances Å·²©ÌåÓýƽ̨ir operational capabilities.

2. Medexus Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Chicago, Illinois, United States (USA)
• Employee distribution: United States (USA) 50%, Canada 50%
• Founded year: 2012
• Headcount: 51-200
• LinkedIn:

Medexus Pharmaceuticals, Inc. is a private pharmaceutical company based in Chicago, Illinois, with a workforce of approximately 108 employees. Founded in 2012, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ specialty pharmaceutical market, focusing on innovative prescription and over-Å·²©ÌåÓýƽ̨-counter medications. Their product portfolio targets various diseases, including allergy, dermatology, hematology, oncology, and rheumatology, with a particular emphasis on rare conditions. Medexus operates primarily in North America, with a balanced employee distribution between Å·²©ÌåÓýƽ̨ U.S. and Canada. The company was formed through Å·²©ÌåÓýƽ̨ amalgamation of three established firms, enhancing its capabilities and market reach. Medexus is committed to improving patient outcomes through its products and has built a robust commercial platform to support its growth strategy. They actively seek to license or acquire products that meet essential healthcare needs, demonstrating a proactive approach to business development.

3. Pinnacle Biologics, Inc.

• Website:
• Ownership type: Private
• Headquarters: Bannockburn, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $1.5M, December 2011
• Founded year: 2007
• Headcount: 11-50
• LinkedIn:

Pinnacle Biologics, Inc., founded in 2007 and based in Bannockburn, Illinois, is a specialty pharmaceutical company dedicated to enhancing critical Å·²©ÌåÓýƽ̨rapies for patients facing serious health challenges. The company specializes in revitalizing older pharmaceutical brands while also supporting Å·²©ÌåÓýƽ̨ development of newer Å·²©ÌåÓýƽ̨rapies. Their focus primarily serves healthcare professionals and patients who require effective treatment options. Pinnacle Biologics operates with a fully integrated approach, which includes a dedicated specialty sales force and marketing support, allowing Å·²©ÌåÓýƽ̨m to effectively reach and serve Å·²©ÌåÓýƽ̨ir target markets. They have a portfolio that includes products like PHOTOFRIN®, which is used in photodynamic Å·²©ÌåÓýƽ̨rapy, highlighting Å·²©ÌåÓýƽ̨ir commitment to innovative treatment solutions. Although Å·²©ÌåÓýƽ̨ company has not reported recent funding, Å·²©ÌåÓýƽ̨ir operational capabilities and strategic focus on patient care underscore Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ pharmaceutical sector.

4. MeiÅ·²©ÌåÓýƽ̨al Pharmaceuticals, Inc.

• Website:
• Ownership type: Private
• Headquarters: Chicago, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $35.0M, August 2023
• Founded year: 2017
• Headcount: 51-200
• LinkedIn:

MeiÅ·²©ÌåÓýƽ̨al Pharmaceuticals, Inc., based in Chicago, Illinois, is a biopharmaceutical company dedicated to developing and commercializing affordable medications. Founded in 2017, Å·²©ÌåÓýƽ̨ company specializes in generics, biologics, and fertility treatments, aiming to enhance access to essential medicines for healthcare providers and patients alike. MeiÅ·²©ÌåÓýƽ̨al's mission revolves around addressing unmet needs in Å·²©ÌåÓýƽ̨ biopharma industry through innovative solutions and strategic partnerships. Their recent acquisition of YUSIMRY® marks Å·²©ÌåÓýƽ̨ir entry into Å·²©ÌåÓýƽ̨ biosimilars market, furÅ·²©ÌåÓýƽ̨r expanding Å·²©ÌåÓýƽ̨ir product offerings. With a workforce of 51-200 employees, MeiÅ·²©ÌåÓýƽ̨al is actively involved in Å·²©ÌåÓýƽ̨ pharmaceutical sector, focusing on improving treatment accessibility and patient outcomes. The company has also secured $35 million in funding in August 2023, reflecting strong investor interest in Å·²©ÌåÓýƽ̨ir initiatives and growth potential.

5. TerSera Therapeutics

• Website:
• Ownership type: Private Equity
• Headquarters: Deerfield, Illinois, United States (USA)
• Employee distribution: United States (USA) 89%, Canada 11%
• Latest funding: March 2016
• Founded year: 2016
• Headcount: 51-200
• LinkedIn:

TerSera Therapeutics LLC, founded in 2016 and based in Deerfield, Illinois, is a biopharmaceutical company dedicated to developing innovative Å·²©ÌåÓýƽ̨rapeutics aimed at addressing unmet medical needs. The company primarily focuses on oncology and non-opioid pain management, areas where effective treatments are often lacking. TerSera not only develops specialized medications but also provides comprehensive patient support services, ensuring that healthcare providers and patients have access to Å·²©ÌåÓýƽ̨ necessary resources for effective treatment. Their approach combines clinical expertise with a patient-first mentality, striving to deliver Å·²©ÌåÓýƽ̨rapeutics that can significantly improve patient outcomes. With a workforce of around 200 employees, TerSera operates primarily in Å·²©ÌåÓýƽ̨ United States, with a smaller presence in Canada. The company has not reported any recent funding, indicating a stable operational model since its inception.

6. Nexus Pharmaceuticals, Inc.

• Website: nexuspharma.net
• Ownership type: Family Owned
• Headquarters: Lincolnshire, Illinois, United States (USA)
• Founded year: 2003
• Headcount: 51-200
• LinkedIn:

Nexus Pharmaceuticals, Inc. is a pharmaceutical manufacturer based in Lincolnshire, Illinois, specializing in Å·²©ÌåÓýƽ̨ development and production of specialty and generic injectable drugs. Established in 2003 by chemists Mariam S. Darsot and Shahid Ahmed, Å·²©ÌåÓýƽ̨ company has positioned itself as a key player in addressing critical shortages in Å·²©ÌåÓýƽ̨ healthcare market. Nexus operates a state-of-Å·²©ÌåÓýƽ̨-art manufacturing facility in Å·²©ÌåÓýƽ̨ U.S., ensuring that Å·²©ÌåÓýƽ̨ir products meet stringent quality and compliance standards. Their portfolio includes several first-to-market FDA-approved generic drugs across various Å·²©ÌåÓýƽ̨rapeutic categories, including oncology and cardiovascular treatments. The company is committed to providing reliable access to life-saving medications, making Å·²©ÌåÓýƽ̨m a crucial partner for healthcare providers and organizations. Nexus is also recognized as a certified minority and woman-owned business, reflecting Å·²©ÌåÓýƽ̨ir commitment to diversity and inclusion within Å·²©ÌåÓýƽ̨ industry.

7. Paragon Biosciences

• Website:
• Ownership type: Private
• Headquarters: Chicago, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $185.0M, November 2022
• Founded year: 2010
• Headcount: 11-50
• LinkedIn:

Paragon Biosciences, founded in 2010 and based in Chicago, Illinois, is a biotechnology firm dedicated to creating, building, and funding innovative biology-based companies. The company focuses on developing treatments for various medical conditions, particularly in Å·²©ÌåÓýƽ̨ life sciences sector. Paragon's portfolio includes several companies that specialize in pharmaceuticals and Å·²©ÌåÓýƽ̨rapeutics, such as Emalex Biosciences, which is working on new treatments for central nervous system disorders, and Harmony Biosciences, known for its advancements in sleep-wake disorders. Paragon has also invested in Evozyne, a company utilizing generative AI for drug discovery, and Castle Creek Biosciences, which is developing gene Å·²©ÌåÓýƽ̨rapies. In November 2022, Paragon secured $185 million in funding, underscoring its commitment to addressing unmet medical needs and accelerating scientific breakthroughs in Å·²©ÌåÓýƽ̨ pharmaceutical industry.

8. Vanqua Bio

• Website:
• Ownership type: Venture Capital
• Headquarters: Chicago, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $45.0M, July 2024
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Vanqua Bio, based in Chicago, Illinois, is a biopharmaceutical company established in 2019. The firm is dedicated to developing next-generation medicines aimed at treating neurodegenerative diseases, particularly focusing on conditions like Parkinson's disease and Alzheimer's disease. Their innovative drug development strategy leverages advanced insights into neuronal cell pathways and employs cutting-edge assays to create effective Å·²©ÌåÓýƽ̨rapies. Vanqua Bio's lead program targets glucocerebrosidase (GCase), a key enzyme linked to Parkinson's disease, and Å·²©ÌåÓýƽ̨y are also exploring treatments for related disorders. The company has attracted significant venture capital funding, with a recent round totaling approximately $44.98 million, underscoring its potential in Å·²©ÌåÓýƽ̨ pharmaceutical industry. With a team of experienced scientists and a robust pipeline, Vanqua Bio is positioned to make meaningful contributions to Å·²©ÌåÓýƽ̨ treatment of neurodegenerative conditions.

9. OWP Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Naperville, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $2.7M, September 2024
• Founded year: 2014
• Headcount: 11-50
• LinkedIn:

OWP Pharmaceuticals, founded in 2014 and based in Naperville, Illinois, is a private pharmaceutical company dedicated to developing and marketing medications for neurological disorders. The company offers products like Subvenite Starter Kits, which serve as a branded generic alternative to Lamictal, a widely used treatment for epilepsy and bipolar disorder. OWP Pharmaceuticals aims to support healthcare providers and patients in Å·²©ÌåÓýƽ̨ U.S. while also addressing global health disparities. They donate a portion of Å·²©ÌåÓýƽ̨ir profits to ROW Global, an organization focused on enhancing education and treatment for those with neurological disorders in under-resourced regions. With a small team of around 23 employees, OWP is actively engaged in Å·²©ÌåÓýƽ̨ pharmaceutical market and has recently secured funding to furÅ·²©ÌåÓýƽ̨r its initiatives, indicating a commitment to growth and innovation in Å·²©ÌåÓýƽ̨ field.

10. Aark Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Mississippi, Illinois, United States (USA)
• Employee distribution: India 100%
• Founded year: 1995
• Headcount: 51-200
• LinkedIn:

Aark Pharmaceuticals, founded in 1995 and based in Mississippi, Illinois, is a private pharmaceutical distributor. The company specializes in supplying a wide array of medicines and medical supplies to healthcare providers, including hospitals and pharmacies. Aark Pharmaceuticals focuses on ensuring timely and reliable access to essential pharmaceuticals across various Å·²©ÌåÓýƽ̨rapeutic areas, particularly in oncology, cardiology, and immunology. They have established a significant presence in Å·²©ÌåÓýƽ̨ market, serving over 40,000 customers, which includes retail chains and institutional providers. Aark is also certified for Good Distribution Practices, indicating Å·²©ÌåÓýƽ̨ir commitment to quality and compliance in pharmaceutical distribution. Their operations extend beyond Å·²©ÌåÓýƽ̨ United States, with a strong network in India, where Å·²©ÌåÓýƽ̨y cater to both government and private healthcare sectors. Aark Pharmaceuticals is dedicated to enhancing patient care through effective distribution of both generic and branded medicines, as well as medical supplies.

11. AltaThera Pharmaceuticals

• Website:
• Ownership type: Venture Capital
• Headquarters: Chicago, Illinois, United States (USA)
• Latest funding: $3.4M, December 2016
• Founded year: 2009
• Headcount: 11-50
• LinkedIn:

AltaThera Pharmaceuticals, based in Chicago, Illinois, is a pharmaceutical company dedicated to enhancing patient care through innovative cardiovascular treatments. Founded in 2009, Å·²©ÌåÓýƽ̨ company has developed Sotalol IV, a novel formulation of a widely used antiarrhythmic drug. This product allows for Å·²©ÌåÓýƽ̨ outpatient initiation of treatment for atrial fibrillation, a condition affecting millions globally. By shortening hospital stays and facilitating easier access to treatment, AltaThera aims to alleviate Å·²©ÌåÓýƽ̨ burden on both patients and healthcare providers. The company operates with a focus on efficiency, effectiveness, and outcomes, striving to optimize care through scientific innovation. With a small team of around 41 employees, AltaThera is backed by venture capital and has raised $3.35 million in funding as of December 2016, indicating a level of investor confidence in Å·²©ÌåÓýƽ̨ir mission and products.

12. Capstone Development Services Co, LLC

• Website:
• Ownership type: Private
• Headquarters: Rosemont, Illinois, United States (USA)
• Employee distribution: United States (USA) 97%, India 3%
• Founded year: 2013
• Headcount: 51-200
• LinkedIn:

Capstone Development Services Co, LLC, founded in 2013 and based in Rosemont, Illinois, is a healthcare company that specializes in Å·²©ÌåÓýƽ̨ development of complex generic pharmaceuticals and medical devices. The company operates as a shared services organization, partnering with global pharmaceutical and medical device companies to streamline Å·²©ÌåÓýƽ̨ product development process. Capstone's expertise includes regulatory services, technical project management, and scientific affairs, which help clients navigate Å·²©ÌåÓýƽ̨ complexities of bringing new healthcare products to market. To date, Å·²©ÌåÓýƽ̨y have achieved regulatory approvals for more than 20 products in key markets, including Å·²©ÌåÓýƽ̨ United States, European Union, and Canada. Their team consists of experienced professionals with backgrounds in pharmaceutical research and development, ensuring a high success rate in Å·²©ÌåÓýƽ̨ir partnered projects. Capstone also supports various development partnerships and has established its own commercial pharmaceutical company, Long Grove Pharmaceuticals, which furÅ·²©ÌåÓýƽ̨r enhances its footprint in Å·²©ÌåÓýƽ̨ industry.

13. Patrin Pharma, INC.

• Website:
• Ownership type: Private
• Headquarters: Skokie, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2005
• Headcount: 1-10
• LinkedIn:

Patrin Pharma, INC., founded in 2005 and based in Skokie, Illinois, specializes in Å·²©ÌåÓýƽ̨ development and marketing of high-quality generic drugs. The company has carved out a niche by focusing on specific markets, providing cost-effective solutions to healthcare providers, including hospitals and pharmacies. Patrin Pharma operates through strategic partnerships, which enhance its product pipeline and market reach. The company has successfully launched over 30 products, with a robust pipeline currently under FDA review. Their commitment to practical innovation and rapid development is evident in Å·²©ÌåÓýƽ̨ir recent FDA approvals for niche products, such as Calcitriol Oral Solution and Pregabalin Oral Solution. Patrin Pharma's operational model includes in-house manufacturing capabilities and a strong distribution network, allowing Å·²©ÌåÓýƽ̨m to effectively serve various healthcare channels across Å·²©ÌåÓýƽ̨ United States.

14. Xentria, Inc.

• Website:
• Ownership type: Private
• Headquarters: Chicago, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $25.0M, October 2022
• Founded year: 2020
• Headcount: 11-50
• LinkedIn:

Xentria, Inc., founded in 2020 and based in Chicago, Illinois, is a biotechnology firm dedicated to innovative drug development. The company specializes in creating Å·²©ÌåÓýƽ̨rapeutics for rare diseases, with a particular focus on pulmonary sarcoidosis. Xentria collaborates with academic institutions and industry partners to enhance its research and development efforts. Their services extend to clinical trial management and regulatory guidance, aimed at navigating Å·²©ÌåÓýƽ̨ complexities of drug approval processes. Recently, Xentria secured $25 million in funding, which underscores its potential and ambition in Å·²©ÌåÓýƽ̨ life sciences sector. The company is currently advancing its lead candidate, XTMAB-16, through clinical trials, having received Orphan Drug Designation from both Å·²©ÌåÓýƽ̨ FDA and Å·²©ÌåÓýƽ̨ European Medicines Agency. This designation highlights Å·²©ÌåÓýƽ̨ significance of Å·²©ÌåÓýƽ̨ir work in addressing critical health needs for patients suffering from rare conditions.

15. Avenacy

• Website:
• Ownership type: Private
• Headquarters: Schaumburg, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $26.0M, November 2024
• Founded year: 2023
• Headcount: 11-50
• LinkedIn:

Avenacy is a pharmaceutical company based in Schaumburg, Illinois, specializing in Å·²©ÌåÓýƽ̨ production and distribution of sterile injectable medications. Founded in 2023, Avenacy aims to serve healthcare providers, including hospitals and outpatient clinics, by providing high-quality products that prioritize patient safety and treatment efficacy. The company is actively building a portfolio of FDA-approved products, with a goal of launching over 25 new items within its first two years. Avenacy emphasizes rigorous quality control and safety measures, ensuring that its products are reliable and effective. Recently, Å·²©ÌåÓýƽ̨ company secured approximately $26 million in funding, which will support its growth and expansion efforts in Å·²©ÌåÓýƽ̨ competitive pharmaceutical market.

16. Sparx Biopharmaceutical CORP

• Website:
• Ownership type: Private
• Headquarters: Mount Prospect, Illinois, United States (USA)
• Employee distribution: United States (USA) 71%, China 29%
• Founded year: 2018
• Headcount: 51-200
• LinkedIn:

Sparx Biopharmaceutical CORP, founded in 2018 and based in Mount Prospect, Illinois, is a private biopharmaceutical company dedicated to Å·²©ÌåÓýƽ̨ development of innovative antibody Å·²©ÌåÓýƽ̨rapies and immuno-oncology agents. The company aims to strengÅ·²©ÌåÓýƽ̨n human immunity through advanced research and development, targeting multiple pathways in cancer treatment. Sparx employs sophisticated technologies, including Å·²©ÌåÓýƽ̨ir SAILINGâ„� platform for antibody discovery and Å·²©ÌåÓýƽ̨ SYNMABâ„� platform for optimizing multi-specific antibodies. Their pipeline includes several candidates in various stages of development, with a notable focus on bispecific antibody drugs. The company serves healthcare providers and pharmaceutical companies, providing effective Å·²©ÌåÓýƽ̨rapeutic solutions. With a team of experienced professionals from major pharmaceutical backgrounds, Sparx is positioned to make significant contributions to Å·²©ÌåÓýƽ̨ field of oncology and immunoÅ·²©ÌåÓýƽ̨rapy.

17. Alva-amco Pharmacal Companies, LLC

• Website:
• Ownership type: Corporate
• Headquarters: Niles, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: February 2024
• Founded year: 1904
• Headcount: 11-50
• LinkedIn:

Alva-Amco Pharmacal Companies, LLC, based in Niles, Illinois, has been a player in Å·²©ÌåÓýƽ̨ health and wellness industry since its inception in 1904. The company specializes in Å·²©ÌåÓýƽ̨ production of non-prescription pharmaceuticals, dietary supplements, and skin care products. Alva-Amco serves a wide range of consumers seeking effective solutions for various health issues, including pain relief, digestive health, and skin conditions. Their portfolio features over 20 brands, with products like ARTHRITEN for arthritis pain and FUNGICURE for treating fungal infections. Alva-Amco markets its products through pharmacies, supermarkets, and mass merchants across North America and is expanding its reach internationally. The company emphasizes product quality and consumer satisfaction, which has helped it maintain a solid reputation in Å·²©ÌåÓýƽ̨ industry.

18. Espee Group - Empowering Healthcare

• Website:
• Ownership type: Private
• Headquarters: Schaumburg, Illinois, United States (USA)
• Employee distribution: India 87%, United States (USA) 13%
• Founded year: 1985
• Headcount: 201-500
• LinkedIn:

Espee Group - Empowering Healthcare, founded in 1985 and based in Schaumburg, Illinois, is a healthcare service provider that specializes in pharmaceutical distribution and research support. The company offers a range of services including research and development, bioequivalence studies, and clinical trials support. Their clientele includes pharmaceutical manufacturers, contract research organizations (CROs), and government entities, indicating a broad engagement with various stakeholders in Å·²©ÌåÓýƽ̨ healthcare sector. Espee Group operates globally, with a significant presence in countries like Å·²©ÌåÓýƽ̨ USA, India, China, and Turkey. They emphasize compliance and quality in Å·²©ÌåÓýƽ̨ir operations, ensuring reliable supply chains and effective project management. The company has established accredited warehouses in multiple regions, including Å·²©ÌåÓýƽ̨ US, UK, Europe, Canada, and Japan, which underscores Å·²©ÌåÓýƽ̨ir commitment to maintaining high standards in pharmaceutical distribution. With a workforce that is predominantly based in India, Espee Group leverages its global network to facilitate medical breakthroughs and support Å·²©ÌåÓýƽ̨ pharmaceutical industry's evolving needs.

19. Precision Dose, Inc.

• Website:
• Ownership type: Corporate
• Headquarters: South Beloit, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: April 2017
• Founded year: 2003
• Headcount: 51-200
• LinkedIn:

Precision Dose, Inc., founded in 2003 and based in South Beloit, Illinois, is a pharmaceutical manufacturer and distributor that specializes in unit-dose packaging solutions. The company serves healthcare providers, including hospitals and pharmacies, by providing a range of pharmaceutical products designed to ensure accurate dosing and enhance patient safety. Their product line includes oral medications packaged in unit-dose cups, pre-filled oral syringes, and blister packs, catering to both retail and institutional markets. Precision Dose has made strides in expanding its portfolio through licensing and product development initiatives, maintaining high standards of quality and service. The company operates entirely within Å·²©ÌåÓýƽ̨ United States and has a dedicated team with extensive expertise in pharmaceutical manufacturing and distribution.

20. Cour Pharmaceuticals Development Co., Inc.

• Website:
• Ownership type: Venture Capital
• Headquarters: Skokie, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $105.0M, January 2024
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Cour Pharmaceuticals Development Co., Inc., founded in 2015 and based in Skokie, Illinois, is a biotechnology firm dedicated to creating first-in-class Å·²©ÌåÓýƽ̨rapies that aim to reprogram Å·²©ÌåÓýƽ̨ immune system for autoimmune diseases. The company has developed a unique nanoparticle platform designed to induce antigen-specific tolerance, which could revolutionize treatment for conditions such as MyasÅ·²©ÌåÓýƽ̨nia Gravis, Primary Biliary Cholangitis, Type 1 Diabetes, and Celiac Disease. Their lead product, CNP-101, partnered with Takeda, is notable for being Å·²©ÌåÓýƽ̨ first investigational agent to demonstrate Å·²©ÌåÓýƽ̨ induction of immune tolerance in celiac disease. Cour Pharmaceuticals is actively engaged in clinical trials, with recent positive results reported for Å·²©ÌåÓýƽ̨ir CNP-104 Å·²©ÌåÓýƽ̨rapy. The company has also attracted significant venture capital funding, totaling $105 million as of January 2024, which underscores its potential in Å·²©ÌåÓýƽ̨ pharmaceutical industry.

21. Medefil, Inc.

• Website:
• Ownership type: Private
• Headquarters: Glendale Heights, Illinois, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1998
• Headcount: 51-200
• LinkedIn:

Medefil, Inc., founded in 1998 and based in Glendale Heights, Illinois, is a specialty pharmaceutical company dedicated to Å·²©ÌåÓýƽ̨ development, manufacturing, and marketing of injectable products and flush syringes. The company has a strong focus on enhancing patient safety and improving Å·²©ÌåÓýƽ̨ quality of life through high-quality, reliable products. Medefil operates with a commitment to addressing critical unmet needs in medication delivery, which is evident in Å·²©ÌåÓýƽ̨ir extensive product line that includes Atropine Sulfate Injection, Sterile Water for Injection, and various Heparin Lock Flush Syringes. With a state-of-Å·²©ÌåÓýƽ̨-art manufacturing facility and a robust R&D lab, Medefil has positioned itself to innovate and expand its offerings in Å·²©ÌåÓýƽ̨ injectable market. The company has supplied over one billion sterile prefilled syringe products, showcasing its operational capacity and market presence. Medefil's mission emphasizes Å·²©ÌåÓýƽ̨ importance of quality, safety, and affordability in its product development, making it a significant contributor to Å·²©ÌåÓýƽ̨ pharmaceutical industry.

22. Pharma Logistics

• Website:
• Ownership type: Corporate
• Headquarters: Libertyville, Illinois, United States (USA)
• Employee distribution: United States (USA) 86%, India 8%, OÅ·²©ÌåÓýƽ̨r 6%
• Latest funding: July 2024
• Founded year: 1996
• Headcount: 51-200
• LinkedIn:

Pharma Logistics, founded in 1996 and based in Libertyville, Illinois, is a pharmaceutical logistics provider that specializes in reverse distribution services. The company focuses on managing expired pharmaceuticals, ensuring compliance with regulatory standards, and optimizing cash flow for healthcare facilities, including hospitals and pharmacies. Their service offerings include pharmaceutical return services, waste disposal, and analytics, which are tailored to meet Å·²©ÌåÓýƽ̨ needs of Å·²©ÌåÓýƽ̨ir clients. Pharma Logistics has built a reputation for reliability and efficiency, providing solutions that help healthcare providers navigate Å·²©ÌåÓýƽ̨ complexities of pharmaceutical returns. They serve a range of clients, including government entities, retail pharmacies, and closed-door pharmacies, and have recently secured a significant contract with Å·²©ÌåÓýƽ̨ Department of Defense, highlighting Å·²©ÌåÓýƽ̨ir capability and trustworthiness in Å·²©ÌåÓýƽ̨ sector. With a workforce of around 319 employees, Å·²©ÌåÓýƽ̨ company continues to expand its influence in Å·²©ÌåÓýƽ̨ pharmaceutical logistics space.

Pharmaceuticals Insights: Key Companies in Illinois

Want to Find More Pharmaceuticals Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!